BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37291189)

  • 21. Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection.
    D'Ambrosi S; Giannoukakos S; Antunes-Ferreira M; Pedraz-Valdunciel C; Bracht JWP; Potie N; Gimenez-Capitan A; Hackenberg M; Fernandez Hilario A; Molina-Vila MA; Rosell R; Würdinger T; Koppers-Lalic D
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA.
    Best MG; In 't Veld SGJG; Sol N; Wurdinger T
    Nat Protoc; 2019 Apr; 14(4):1206-1234. PubMed ID: 30894694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer.
    Sheng M; Dong Z; Xie Y
    Onco Targets Ther; 2018; 11():8143-8151. PubMed ID: 30532555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients.
    Zhang Q; Hu H; Liu H; Jin J; Zhu P; Wang S; Shen K; Hu Y; Li Z; Zhan P; Zhu S; Fan H; Zhang J; Lv T; Song Y
    Biomed Pharmacother; 2018 Sep; 105():204-214. PubMed ID: 29857300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
    Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
    Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer.
    Park CK; Kim JE; Kim MS; Kho BG; Park HY; Kim TO; Shin HJ; Cho HJ; Choi YD; Oh IJ; Kim YC
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2071-2082. PubMed ID: 31154543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-educated leukocytes mRNA as a diagnostic biomarker for non-small cell lung cancer.
    Niu L; Guo W; Song X; Song X; Xie L
    Thorac Cancer; 2021 Mar; 12(6):737-745. PubMed ID: 33474835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.
    Ying L; Du L; Zou R; Shi L; Zhang N; Jin J; Xu C; Zhang F; Zhu C; Wu J; Chen K; Huang M; Wu Y; Zhang Y; Zheng W; Pan X; Chen B; Lin A; Tam JKC; van Dam RM; Lai DTM; Chia KS; Zhou L; Too HP; Yu H; Mao W; Su D
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25036-25042. PubMed ID: 32943537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer.
    Buszka K; Ntzifa A; Owecka B; Kamińska P; Kolecka-Bednarczyk A; Zabel M; Nowicki M; Lianidou E; Budna-Tukan J
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNAs and
    Luo CL; Xu ZG; Chen H; Ji J; Wang YH; Hu W; Wang K; Zhang WW; Yuan CH; Wang FB
    Cancer Manag Res; 2018; 10():1449-1459. PubMed ID: 29922089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation biomarkers discovered
    Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
    Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of seven tumor-educated platelets RNAs for cancer diagnosis.
    Ge X; Yuan L; Cheng B; Dai K
    J Clin Lab Anal; 2021 Jun; 35(6):e23791. PubMed ID: 33955587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
    Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
    Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
    Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.